The need for a better dengue vaccine becomes increasingly urgent
A public research institute in Brazil has proven that a new vaccine protects against the disease, but it cannot do so quickly enough to stop the huge epidemic sweeping across Latin America. .
The dengue epidemic that broke out in Latin America over the last three months is of staggering scale: one million cases in Brazil in just a few weeks, a huge spike in Argentina, a state of emergency declared in Peru and now another in Puerto Rico.
This suggests a change in the landscape of disease. Mosquitoes that spread dengue thrive in densely populated cities with weak infrastructure, as well as warmer, more humid environments – the type of habitat that is growing rapidly with climate change.
More than 3.5 million cases of dengue fever have been confirmed by Latin American governments in the first three months of 2024, compared to 4.5 million for all of 2023. There have been more than 1,000 deaths so far this year. The Pan American Health Organization warns that this year could be the worst year on record for dengue.
Rapidly changing disease landscape requires new solutions , and Brazilian researchers provided the The only good news in this story is the recent announcement that a clinical trial of a new dengue vaccine, administered in a single injection, had provided strong protection against the disease.< /p> There are two vaccines against dengue fever, but one is an expensive two-way regimen injections, while the other can only be given to people who have had a previous dengue infection. We are having difficulty retrieving the content of the article . Please enable JavaScript in your browser settings. Thank you for your patience while we verify access. If you are in Reader mode, please exit and log in to your Times account, or subscribe to the entire Times.
A public research institute in Brazil has proven that a new vaccine protects against the disease, but it cannot do so quickly enough to stop the huge epidemic sweeping across Latin America. .
The dengue epidemic that broke out in Latin America over the last three months is of staggering scale: one million cases in Brazil in just a few weeks, a huge spike in Argentina, a state of emergency declared in Peru and now another in Puerto Rico.
This suggests a change in the landscape of disease. Mosquitoes that spread dengue thrive in densely populated cities with weak infrastructure, as well as warmer, more humid environments – the type of habitat that is growing rapidly with climate change.
More than 3.5 million cases of dengue fever have been confirmed by Latin American governments in the first three months of 2024, compared to 4.5 million for all of 2023. There have been more than 1,000 deaths so far this year. The Pan American Health Organization warns that this year could be the worst year on record for dengue.
Rapidly changing disease landscape requires new solutions , and Brazilian researchers provided the The only good news in this story is the recent announcement that a clinical trial of a new dengue vaccine, administered in a single injection, had provided strong protection against the disease.< /p> There are two vaccines against dengue fever, but one is an expensive two-way regimen injections, while the other can only be given to people who have had a previous dengue infection. We are having difficulty retrieving the content of the article . Please enable JavaScript in your browser settings. Thank you for your patience while we verify access. If you are in Reader mode, please exit and log in to your Times account, or subscribe to the entire Times.
What's Your Reaction?
